June 5 (Reuters) - Virtual chronic care provider Omada Health said on Thursday it had raised $150 million in its U.S. initial public offering, another sign of recovering investor appetite for new stocks.
Although U.S. President Donald Trump's shifting tariff policies have weighed on markets, companies in resilient and even high-risk sectors, such as crypto firm Circle, are testing investor appetite with new listings.
The company sold 7.9 million shares in the IPO priced at $19 each, in the middle of its marketed range of $18 to $20.
Omada shares are set to begin trading on the Nasdaq under the symbol "OMDA" on Friday.
The success of recent listings could encourage more companies to tap the IPO market, especially as investor confidence slowly rebuilds after a prolonged slowdown.
Founded in 2012, Omada offers virtual care programs for patients with chronic conditions such as prediabetes, diabetes and hypertension. Its prospectus describes the company's approach as a "between-visit care model" designed to complement the broader healthcare system.
Morgan Stanley, JPMorgan, and Goldman Sachs are among the underwriters for the company's offering.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.